Asymmetric Dimethyarginine as Marker and Mediator in Ischemic Stroke

Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is known as mediator of endothelial cell dysfunction and atherosclerosis. Circulating ADMA levels are correlated with cardiovascular risk factors such as hypercholesterolemia, arterial hypertension, diabetes mel...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shufen, Li, Na, Deb-Chatterji, Milani, Dong, Qiang, Kielstein, Jan T., Weissenborn, Karin, Worthmann, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546674/
https://www.ncbi.nlm.nih.gov/pubmed/23443106
http://dx.doi.org/10.3390/ijms131215983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546674/
https://www.ncbi.nlm.nih.gov/pubmed/23443106
http://dx.doi.org/10.3390/ijms131215983

Ejemplares similares